Pharmaceuticals by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 61 pharmaceuticals ranked by one-year price change, at +403%, ahead of Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%). Figures as of 18 Nov 2026, 14:51 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Erasca+403%
- Median
- +26.9%
- Combined market value
- SAR 19.23T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +403% | SAR 17.7B | SAR 50.34 | 3.38% down | 403% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +286% | SAR 33.7B | SAR 354.51 | 0.75% up | 286% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +241% | SAR 24.8B | SAR 365.38 | 1.13% up | 241% up | ||
| 4 | VeradermicsMANE · Health Care | +233% | SAR 20B | SAR 474.69 | 0.72% up | 233% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +169% | SAR 15B | SAR 109.75 | 0.41% down | 169% up | ||
| 6 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +126% | SAR 28.5B | SAR 362.87 | 1.71% up | 126% up | ||
| 7 | Dianthus TherapeuticsDNTH · Health Care | +113% | SAR 18.3B | SAR 324.93 | 0.41% down | 113% up | ||
| 8 | TG TherapeuticsTGTX · Health Care | +107% | SAR 35.6B | SAR 235.45 | 0.10% up | 107% up | ||
| 9 | ViatrisVTRS · Health Care | +95.5% | SAR 88.2B | SAR 76.96 | 0.32% up | 96% up | ||
| 10 | Roivant SciencesROIV · Health Care | +90.3% | SAR 104.9B | SAR 144.79 | 0.28% down | 90% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | +88.2% | SAR 16.8B | SAR 153.90 | 2.40% down | 88% up | ||
| 12 | Amneal PharmaceuticalsAMRX · Health Care | +83.3% | SAR 27.7B | SAR 79.45 | 0.28% up | 83% up | ||
| 13 | Royalty PharmaRPRX · Health Care | +77.7% | SAR 147.9B | SAR 257.21 | 0.16% down | 78% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | +74.4% | SAR 187.3B | SAR 160.49 | 0.41% up | 74% up | ||
| 15 | GenmabGMAB · Health Care | +70.0% | SAR 119.6B | SAR 193.93 | 0.50% down | 70% up | ||
| 16 | Praxis Precision MedicinesPRAX · Health Care | +61.1% | SAR 32B | SAR 1,143.21 | 0.09% down | 61% up | ||
| 17 | AlkermesALKS · Health Care | +58.4% | SAR 29.1B | SAR 173.26 | 1.63% up | 58% up | ||
| 18 | Takeda PharmaceuticalTAK · Health Care | +53.6% | SAR 257.8B | SAR 80.68 | 0.62% down | 54% up | ||
| 19 | Merck & CoMRK · Health Care | +50.8% | SAR 1.3T | SAR 527.35 | 1.94% down | 51% up | ||
| 20 | Protagonist TherapeuticsPTGX · Health Care | +46.4% | SAR 30.4B | SAR 465.54 | 0.45% down | 46% up | ||
| 21 | Travere TherapeuticsTVTX · Health Care | +44.2% | SAR 18.1B | SAR 188.79 | 1.51% down | 44% up | ||
| 22 | Ligand PharmaceuticalsLGND · Health Care | +42.6% | SAR 22B | SAR 1,101.71 | 0.03% down | 43% up | ||
| 23 | Johnson & JohnsonJNJ · Health Care | +37.6% | SAR 2.5T | SAR 1,039.25 | 0.59% down | 38% up | ||
| 24 | Jazz PharmaceuticalsJAZZ · Health Care | +36.7% | SAR 58B | SAR 903.33 | 0.05% up | 37% up | ||
| 25 | Regeneron PharmaceuticalsREGN · Health Care | +36.3% | SAR 373.1B | SAR 3,606.32 | 0.38% up | 36% up | ||
| 26 | Eli LillyLLY · Health Care | +34.9% | SAR 4.71T | SAR 5,291.57 | 0.34% down | 35% up | ||
| 27 | Bristol-Myers SquibbBMY · Health Care | +34.0% | SAR 464.9B | SAR 227.42 | 1.22% down | 34% up | ||
| 28 | Belite BioBLTE · Health Care | +31.0% | SAR 24.2B | SAR 596.41 | 0.81% up | 31% up | ||
| 29 | Mirum PharmaceuticalsMIRM · Health Care | +30.5% | SAR 22.5B | SAR 345.04 | 0.04% up | 31% up | ||
| 30 | Ascendis PharmaASND · Health Care | +27.8% | SAR 65.9B | SAR 1,004.29 | 1.27% down | 28% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +26.9% | SAR 510.4B | SAR 2,013.14 | 0.47% up | 27% up | ||
| 32 | AbbVieABBV · Health Care | +25.7% | SAR 1.93T | SAR 1,089.33 | 0.84% down | 26% up | ||
| 33 | NovartisNVS · Health Care | +25.0% | SAR 1.11T | SAR 589.88 | 1.18% down | 25% up | ||
| 34 | United TherapeuticsUTHR · Health Care | +22.6% | SAR 92.8B | SAR 2,178.13 | 0.59% down | 23% up | ||
| 35 | Elanco Animal HealthELAN · Health Care | +20.5% | SAR 49B | SAR 97.94 | 1.01% up | 20% up | ||
| 36 | BridgeBio PharmaBBIO · Health Care | +17.2% | SAR 55.9B | SAR 287.08 | 0.35% down | 17% up | ||
| 37 | BeOne MedicinesONC · Health Care | +16.8% | SAR 174.3B | SAR 1,525.83 | 1.57% down | 17% up | ||
| 38 | PfizerPFE · Health Care | +14.4% | SAR 605.4B | SAR 106.21 | 0.54% down | 14% up | ||
| 39 | Rhythm PharmaceuticalsRYTM · Health Care | +13.0% | SAR 29.9B | SAR 431.03 | 1.46% down | 13% up | ||
| 40 | BioMarin PharmaceuticalBMRN · Health Care | +11.3% | SAR 42.6B | SAR 220.18 | 0.32% up | 11% up | ||
| 41 | Arrowhead PharmaceuticalsARWR · Health Care | +10.3% | SAR 22.7B | SAR 160.79 | 0.29% down | 10% up | ||
| 42 | GSKGSK · Health Care | +6.26% | SAR 370.1B | SAR 184.66 | 0.02% down | 6% up | ||
| 43 | Dr. Reddy's LaboratoriesRDY · Health Care | +5.27% | SAR 46.8B | SAR 56.11 | 1.15% up | 5% up | ||
| 44 | AstraZenecaAZN · Health Care | +2.41% | SAR 1.05T | SAR 676.79 | 0.98% down | 2% up | ||
| 45 | GrifolsGRFS · Health Care | +1.41% | SAR 22.1B | SAR 32.45 | 0.23% up | 1% up | ||
| 46 | SanofiSNY · Health Care | -4.08% | SAR 428.2B | SAR 178.32 | 0.02% up | 4% down | ||
| 47 | Axsome TherapeuticsAXSM · Health Care | -7.37% | SAR 26.5B | SAR 503.61 | 1.24% down | 7% down | ||
| 48 | Corcept TherapeuticsCORT · Health Care | -7.92% | SAR 28.5B | SAR 260.08 | 1.05% down | 8% down | ||
| 49 | Novo NordiskNVO · Health Care | -16.9% | SAR 663.3B | SAR 150.49 | 1.43% down | 17% down | ||
| 50 | Abbott LaboratoriesABT · Health Care | -17.0% | SAR 680.6B | SAR 392.95 | 0.00% | 17% down | ||
| 51 | PTC TherapeuticsPTCT · Health Care | -20.2% | SAR 18.8B | SAR 225.17 | 0.55% down | 20% down | ||
| 52 | CytokineticsCYTK · Health Care | -20.3% | SAR 27.1B | SAR 194.64 | 0.46% up | 20% down | ||
| 53 | Cogent BiosciencesCOGT · Health Care | -20.3% | SAR 18.4B | SAR 105.97 | 1.44% up | 20% down | ||
| 54 | Madrigal PharmaceuticalsMDGL · Health Care | -24.0% | SAR 36.2B | SAR 1,559.19 | 1.50% down | 24% down | ||
| 55 | ABIVAXABVX · Health Care | -27.3% | SAR 27.4B | SAR 312.93 | 1.61% up | 27% down | ||
| 56 | ZoetisZTS · Health Care | -28.7% | SAR 128.5B | SAR 316.21 | 0.98% up | 29% down | ||
| 57 | Summit TherapeuticsSMMT · Health Care | -35.6% | SAR 32.2B | SAR 40.25 | 0.56% up | 36% down | ||
| 58 | InsmedINSM · Health Care | -40.1% | SAR 99.8B | SAR 454.70 | 0.53% down | 40% down | ||
| 59 | Legend BiotechLEGN · Health Care | -42.5% | SAR 12B | SAR 61.95 | 2.52% up | 42% down | ||
| 60 | Ionis PharmaceuticalsIONS · Health Care | -63.6% | SAR 16.9B | SAR 101.57 | 0.43% up | 64% down | ||
| 61 | Alnylam PharmaceuticalsALNY · Health Care | -66.0% | SAR 77.7B | SAR 579.75 | 1.24% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR).
Questions and answers
Which pharmaceuticals rank first by one-year price change?
Erasca (+403%), Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%) are the top three of the 61 pharmaceuticals ranked by one-year price change as of 18 Nov 2026, 14:51 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by one-year price change.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by one-year price change have a combined market value of SAR 19.23T as of 18 Nov 2026, 14:51 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceuticals by one-year price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.